- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06593470
Op mindfulness gebaseerde drugsgebruik Preventie (MINDS-UP) (MINDS-UP)
Mindfulness-gebaseerde middelengebruik Preventie (MINDS-UP): een gerandomiseerde gecontroleerde studie
The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The aims of the study are:
Aim 1: Determine feasibility and acceptability of MINDS-UP as a preventive intervention via a) retention, b) attendance, c) teacher-rated participation, d) student-rated participation, e) homework completion, and f) acceptability.
Aim 2: Evaluate neuropsychological mechanisms (target engagement) of MINDS-UP.
Aim 3 (Exploratory): Assess preliminary efficacy of MINDS-UP on substance use initiation (SUI).
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: David C Saunders, MD, PhD
- Telefoonnummer: 914-409-6807
- E-mail: david.saunders@nyspi.columbia.edu
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
- Youth has access to a smartphone, tablet, or computer with Wi-Fi
- Youth and parent are English-speaking
Exclusion Criteria:
1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Sport: Prevention Plus Wellness (PPW)
Sport: Prevention Plus Wellness (PPW) is a brief, evidence-based substance use prevention program for youth. PPW consists of a single self-administered 45-minute session that is interactive and intended for use by youth in the home setting. It involves screening youth to increase awareness of their current health behaviors; motivational enhancement for change; and establishing a behavior goal plan. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Andere namen:
|
|
Experimenteel: PPW + MINDS-UP
MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Participants randomized to MINDS-UP will also complete PPW, a 45 minute, self-administered course. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Andere namen:
MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Retention
Tijdsspanne: Completion of Study (up to 36 months)
|
Percent of participants who completed all study procedures among those who were randomized |
Completion of Study (up to 36 months)
|
|
Attendance
Tijdsspanne: Completion of Study (up to 36 months)
|
Percent of scheduled sessions that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Teacher Rated Participation
Tijdsspanne: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Teacher Rated |
Completion of Study (up to 36 months)
|
|
Student-Rated Participation
Tijdsspanne: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Student Engagement |
Completion of Study (up to 36 months)
|
|
Homework Completion
Tijdsspanne: Completion of Study (up to 36 months)
|
Percentage of assigned homeworks that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Acceptability
Tijdsspanne: Completion of Study (up to 36 months)
|
Acceptability of Intervention Measure |
Completion of Study (up to 36 months)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Total Problems (parent-report)
Tijdsspanne: 4-8 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems |
4-8 weeks, 6 months, and 12 months
|
|
ADHD Symptoms
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the ADHD Rating Scale, an 18-item parent-report assessment that measures adolescent behaviors related to ADHD (inattentiveness, hyperactivity). |
4-6 weeks, 6 months, and 12 months
|
|
Suicidal Thoughts/Behaviors
Tijdsspanne: 4-6 weeks, 6 months, 12 months
|
The C-SSRS is a gold-standard assessment tool for suicide risk. This tool will be administered at every visit. |
4-6 weeks, 6 months, 12 months
|
|
Alcohol sipping
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip. |
4-6 weeks, 6 months, and 12 months
|
|
Tobacco Use
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use. |
4-6 weeks, 6 months, and 12 months
|
|
Cannabis Use
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis. |
4-6 weeks, 6 months, and 12 months
|
|
Total Problems (adolescent report)
Tijdsspanne: 4-6 weeks, 6 months, 12 months
|
The Youth Self Report (YSR) is the self-report adolescent version of the Child Behavior Checklist, and is used to assess emotional and behavioral problems in children and adolescents. |
4-6 weeks, 6 months, 12 months
|
|
Mindfulness
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness |
4-6 weeks, 6 months, and 12 months
|
|
Anxiety and Depression
Tijdsspanne: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains. |
4-6 weeks, 6 months, and 12 months
|
|
Perceived Tolerance of Use
Tijdsspanne: baseline
|
The Perceived Tolerance of Use is a tool that assesses peer tolerance of use of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is a tool that is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Perceived Harm of Substance Use
Tijdsspanne: baseline
|
The Perceived Harm of Substance Use tool assesses perceived harm of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Beliefs About Alcohol Effects
Tijdsspanne: baseline
|
The Brief Comprehensive Effects of Alcohol Questionnaire is a 15-item self-report version of the Comprehensive Effects of Alcohol Questionnaire that is used by the ABCD study to assess an adolescent's expectations of using alcohol. |
baseline
|
|
Beliefs About Smoking Effects
Tijdsspanne: baseline
|
The Adolescent Smoking Consequences Questionnaire (ASCQ) is a 30-item self-report instrument used to assess outcome expectancies of cigarette smoking among adolescents. |
baseline
|
|
Beliefs About Cannabis Effects
Tijdsspanne: baseline
|
Brief -Marijuana Effect Expectancies Questionnaire (MEEQ-B) is a 6-item self-report assessment of an adolescent's expected effect of marijuana. |
baseline
|
|
Risk and Protective Factors
Tijdsspanne: Baseline
|
The Community Risk and Protective Factors Survey is a 24-item parent-report tool to assess adolescent's experience of exposure to substance use risk and protective factors in the community. |
Baseline
|
Medewerkers en onderzoekers
Medewerkers
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- #Pro00076319
- K12DA000357 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .